½ÃÀ庸°í¼­
»óǰÄÚµå
1594020

ÀÇ·á¿ë ÁÖÀÔ ¹é ½ÃÀå : Á¦Ç° À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Medical Fluid Bags Market by Product Type (Biohazard Disposable Bag, Blood Bags, Breast Milk Bag), End-User (Blood Banks, Clinics & Hospitals, Diagnostic Centers) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 197 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀÇ·á¿ë ÁÖÀÔ ¹é ½ÃÀåÀº 2023³â¿¡ 27¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2024³â¿¡´Â 29¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 6.46%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 42¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÇ·á¿ë ÁÖÀÔ ¹é ½ÃÀå¿¡´Â ½Ä¿°¼ö, Ç÷¾×, ¿µ¾çÁ¦¿Í °°Àº ¾×ü¸¦ ÀúÀåÇϰí ȯÀÚ¿¡°Ô °ø±ÞÇÏ´Â µ¥ »ç¿ëµÇ´Â ´Ù¾çÇÑ °¡¹æÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀåÀº º´¿ø, Ŭ¸®´Ð ¹× °¡Á¤ ÇコÄɾî ȯ°æ¿¡¼­ÀÇ ¿ëµµ¸¦ ´Ù·ç¸ç ÁÖÀÔ °¡¹æ, Ç÷¾×¹é ¹× Åõ¼® °¡¹æ°ú °°Àº ´Ù¾çÇÑ À¯Çü¿¡ ÁßÁ¡À» µÓ´Ï´Ù. ÀÇ·á¿ë ÁÖÀÔ ¹éÀÇ Çʿ伺Àº Áß¿äÇÑ ¼ö¾×°ú ¾à¹°À» ¾ÈÀüÇϰí È¿À²ÀûÀ¸·Î °ø±ÞÇϰí ȯÀÚ Ä¡·á¿¡ ÇʼöÀûÀÎ À§»ýÀûÀ̰í ÅëÁ¦µÈ Åõ¿©¸¦ º¸ÀåÇÏ´Â Áß¿äÇÑ ¿ªÇÒ¿¡¼­ ºñ·ÔµË´Ï´Ù. ÀÇ·á ½Ã¼ú, ÀÀ±Þ ½Ã¼ú, ¿µ¾ç °ø±Þ, »ý¸í À¯Áö µîÀÇ ¿ëµµ·Î »ç¿ëµÇ¾î ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼­ ±× Á߿伺ÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ[2023] 27¾ï 6,000¸¸ ´Þ·¯
¿¹Ãø³â[2024] 29¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø³â[2030] 42¾ï 9,000¸¸ ´Þ·¯
CAGR(%) 6.46%

½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ¸¸¼ºÁúȯ°ú ¼ö¼ú Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ÀÇ·á ÀÎÇÁ¶óÀÇ ¹ßÀü°ú °°Àº ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. °¨¿°°ü¸®¿¡ ´ëÇÑ ÀνÄÀÌ ´õ¿í´õ ¼ö¿ä¸¦ ÀÚ±ØÇϰí ÀÖ½À´Ï´Ù. ģȯ°æ ¹× »ýºÐÇØ¼º ¼ÒÀçÀÇ °³¹ß, ¼ö¾×À» ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÏ°í °ü¸®ÇÒ ¼ö ÀÖ´Â ½º¸¶Æ® ÀÇ·á±â±âÀÇ °³¹ß µî ±â¼ú Çõ½ÅÀÇ ÇüÅ·Π±âȸ¸¦ âÃâÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¼ú ±â¾÷°úÀÇ Çù¾÷Àº Áö¼Ó°¡´É¼º µ¿Çâ¿¡ ºÎÇÕÇϰí ȯÀÚ Ä¡·á¸¦ °­È­ÇÏ´Â Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù.

±×·¯³ª ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØ, ÷´Ü Á¦Ç°ÀÇ ³ôÀº ºñ¿ë, ÀáÀçÀûÀÎ Àç·á ´©Ãâ ¹× °¨¿° µîÀÇ ¹®Á¦°¡ ½ÃÀå È®´ëÀÇ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Áö¿ª °£ ÀÇ·áºñ ÁöÃâÀÇ ÆíÂ÷´Â ½ÃÀåÀÇ ±ÕÀϼº°ú ¼ºÀå·ü¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ÀÌ·¯ÇÑ Á¦¾àÀ» ±Øº¹Çϱâ À§ÇØ Àúºñ¿ëÀÇ ³»±¸¼º ³ôÀº ¼ÒÀç °³¹ß, Á¦Ç° ¾ÈÀü ±â´É °­È­ µî ´Ù¾çÇÑ ¹æ¹ýÀ» ¸ð»öÇÒ ¼ö ÀÖ½À´Ï´Ù.

¼¾¼­°¡ ÅëÇÕµÈ À¯Ã¼ °ü¸® ½Ã½ºÅÛ °³¹ß¿¡ ÁýÁßÇϰųª ÀçȰ¿ë °¡´ÉÇÑ ¼ÒÀ縦 ã´Â °ÍÀº ±ÔÁ¦±â°ü°ú ȯ°æ ģȭÀûÀÎ ÀÌÇØ°ü°èÀÚ ¸ðµÎ¿¡°Ô ¾îÇÊÇϰí Çõ½ÅÀ» ÃËÁøÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀº ¿ªµ¿ÀûÀÌ°í ¼¼°è ÇコÄÉ¾î µ¿Çâ¿¡ Å©°Ô ¿µÇâÀ» ¹Þ±â ¶§¹®¿¡ ÀûÀÀ·ÂÀ» À¯ÁöÇϰí Àç·á °úÇÐ ¹× IoT ±â¹Ý °Ç°­ ¼Ö·ç¼Ç ¿¬±¸¿¡ ÅõÀÚÇÏ´Â °ÍÀº ÀÌ ºÐ¾ß¿¡¼­ Áö¼ÓÀûÀÎ ¼ºÀå°ú °æÀï ¿ìÀ§¸¦ È®º¸ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ÀÇ·á¿ë ÁÖÀÔ ¹é ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÀÇ·á¿ë ÁÖÀÔ ¹é ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¿ªÀû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ¿ÏÈ­Çϰí, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÉÀå, ½ÅÀå ¹× °£ Áúȯ, ¾Ï µî ¸¸¼ºÁúȯÀÇ À¯Çà
    • Àü ¼¼°è ¿Ü°ú¼ö¼ú °Ç¼ö ±ÞÁõ
    • ³ë·É Àα¸ ¹× ¿µ¾ç½ÇÁ¶ Àα¸ Áõ°¡
    • ³ôÀº Ãâ»êÀ²°ú Á¶»êÀ²
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • °¡°Ý º¯µ¿ ¹× ¿øÀÚÀç °¡¿ë¼º ÇѰè
  • ½ÃÀå ±âȸ
    • ÀǾàǰ ¿À¿° ¹æÁö¸¦ À§ÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ½Ã³ª¸®¿À
    • À¯¸®ÇÑ »óȯ Á¤Ã¥ ¹× ÇコÄÉ¾î ¼¾ÅÍ Áõ°¡
  • ½ÃÀå °úÁ¦
    • ÇÃ¶ó½ºÆ½ ÁÖÀÔ ¹é »ç¿ë

Porter's Five Forces : ÀÇ·á¿ë ÁÖÀÔ ¹é ½ÃÀåÀ» Ž»öÇÏ´Â Àü·«Àû Åø

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÀÇ·á¿ë ÁÖÀÔ ¹é ½ÃÀå¿¡¼­ÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÀÇ·á¿ë ÁÖÀÔ ¹é ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ÀÇ·á¿ë ÁÖÀÔ ¹é ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

ÀÇ·á¿ë ÁÖÀÔ ¹é ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ÀÇ·á¿ë ÁÖÀÔ ¹é ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀÇ·á¿ë ÁÖÀÔ ¹é ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë ÁÖÀÔ ¹é ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

ÀÇ·á¿ë ÁÖÀÔ ¹é ½ÃÀåÀÇ Àü·«Àû ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù. :

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù. :

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÔ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ÀÇ·á¿ë ÁÖÀÔ ¹é ½ÃÀå : Á¦Ç° À¯Çüº°

  • ¹ÙÀÌ¿ÀÇØÀúµå ÀÏȸ¿ë ¹é
  • Ç÷¾× ¹é
  • ¸ðÀ¯ ¹é
  • Åõ¼® ¹é
  • ¹è¼ö ¹é
  • °üÀå ¹é
  • ½Ã¾à ¹é

Á¦7Àå ÀÇ·á¿ë ÁÖÀÔ ¹é ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • Ç÷¾×ÀºÇà
  • Ŭ¸®´Ð°ú º´¿ø
  • Áø´Ü ¼¾ÅÍ
  • ȨÄÉ¾î ¼³Á¤

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀÇ·á¿ë ÁÖÀÔ ¹é ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÇ·á¿ë ÁÖÀÔ ¹é ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÇ·á¿ë ÁÖÀÔ ¹é ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • ConvaTec Inc.
  • Fosmo Med, Inc.|
  • Fresenius Kabi AG
  • ICU Medical Inc.
  • Kawasumi Laboratories. Inc.
  • Kraton Corporation.
  • McKesson Medical-Surgical Inc.
  • Pall Corporation
  • Pfizer Inc.
  • Polifarma Ilac San. ve Tic. A.S.
  • RENOLIT SE
  • Sippex IV bag
  • Wipak Walothen Gmbh
KSA 24.11.22

The Medical Fluid Bags Market was valued at USD 2.76 billion in 2023, expected to reach USD 2.94 billion in 2024, and is projected to grow at a CAGR of 6.46%, to USD 4.29 billion by 2030.

The medical fluid bags market encompasses a variety of bags used for storing and delivering fluids such as saline, blood, and nutrients to patients. This market covers applications in hospitals, clinics, and home healthcare settings, focusing on different types such as IV bags, blood bags, and dialysis bags. The necessity of medical fluid bags arises from their critical role in the safe and efficient delivery of vital fluids and medications, ensuring hygienic and controlled administration essential for patient care. End-use scope includes usage in medical procedures, emergency care, nutritional support, and life-saving treatments, emphasizing their importance in diverse healthcare environments.

KEY MARKET STATISTICS
Base Year [2023] USD 2.76 billion
Estimated Year [2024] USD 2.94 billion
Forecast Year [2030] USD 4.29 billion
CAGR (%) 6.46%

Driving market growth are factors such as the increasing prevalence of chronic diseases and surgical procedures, rising elderly population, and advancements in healthcare infrastructure. Awareness about infection control further stimulates demand. Opportunities present themselves in the form of technological innovation, such as developing eco-friendly or biodegradable materials, and smart medical devices that allow for real-time monitoring and management of fluid delivery. Collaborations with technology firms can lead to innovative solutions that align with sustainability trends and enhance patient care.

However, challenges such as stringent regulatory standards, high costs of advanced products, and potential material leakage or infection pose hurdles to market expansion. Additionally, variability in healthcare spending across regions can impact market uniformity and growth rates. Companies can explore areas such as developing low-cost, high-durability materials, and enhancing product safety features to overcome these limitations.

Innovation can be driven by focusing on development in sensor-integrated fluid management systems and exploring recyclable materials, which appeals to both regulatory bodies and environmentally conscious stakeholders. As the market is dynamic and heavily influenced by global healthcare trends, maintaining adaptability and investing in research on material sciences and IoT-based health solutions can be pivotal for sustained growth and competitive advantage in this sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Medical Fluid Bags Market

The Medical Fluid Bags Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of chronic diseases such as heart, kidney & liver disorders, and cancer
    • Surge in the number of surgical procedures across the globe
    • Increasing rate of geriatric population and malnourished individuals
    • High natality and premature birth rate
  • Market Restraints
    • Fluctuating price and limited availability of raw material
  • Market Opportunities
    • Stringent regulatory scenarios for prevention of drug contamination
    • Favourable reimbursement policies and the growing number of healthcare centers
  • Market Challenges
    • Use of plastic fluid bags

Porter's Five Forces: A Strategic Tool for Navigating the Medical Fluid Bags Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Medical Fluid Bags Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Medical Fluid Bags Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Medical Fluid Bags Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Medical Fluid Bags Market

A detailed market share analysis in the Medical Fluid Bags Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Medical Fluid Bags Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Medical Fluid Bags Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Medical Fluid Bags Market

A strategic analysis of the Medical Fluid Bags Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Medical Fluid Bags Market, highlighting leading vendors and their innovative profiles. These include B. Braun Melsungen AG, Baxter International Inc., ConvaTec Inc., Fosmo Med, Inc. |, Fresenius Kabi AG, ICU Medical Inc., Kawasumi Laboratories. Inc., Kraton Corporation., McKesson Medical-Surgical Inc., Pall Corporation, Pfizer Inc., Polifarma Ilac San. ve Tic. A.S., RENOLIT SE, Sippex IV bag, and Wipak Walothen Gmbh.

Market Segmentation & Coverage

This research report categorizes the Medical Fluid Bags Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Biohazard Disposable Bag, Blood Bags, Breast Milk Bag, Dialysis Bags, Drain Bags, Enema Bags, and Reagent Bag.
  • Based on End-User, market is studied across Blood Banks, Clinics & Hospitals, Diagnostic Centers, and Homecare Settings.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases such as heart, kidney & liver disorders, and cancer
      • 5.1.1.2. Surge in the number of surgical procedures across the globe
      • 5.1.1.3. Increasing rate of geriatric population and malnourished individuals
      • 5.1.1.4. High natality and premature birth rate
    • 5.1.2. Restraints
      • 5.1.2.1. Fluctuating price and limited availability of raw material
    • 5.1.3. Opportunities
      • 5.1.3.1. Stringent regulatory scenarios for prevention of drug contamination
      • 5.1.3.2. Favourable reimbursement policies and the growing number of healthcare centers
    • 5.1.4. Challenges
      • 5.1.4.1. Use of plastic fluid bags
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medical Fluid Bags Market, by Product Type

  • 6.1. Introduction
  • 6.2. Biohazard Disposable Bag
  • 6.3. Blood Bags
  • 6.4. Breast Milk Bag
  • 6.5. Dialysis Bags
  • 6.6. Drain Bags
  • 6.7. Enema Bags
  • 6.8. Reagent Bag

7. Medical Fluid Bags Market, by End-User

  • 7.1. Introduction
  • 7.2. Blood Banks
  • 7.3. Clinics & Hospitals
  • 7.4. Diagnostic Centers
  • 7.5. Homecare Settings

8. Americas Medical Fluid Bags Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Medical Fluid Bags Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Medical Fluid Bags Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. B. Braun Melsungen AG
  • 2. Baxter International Inc.
  • 3. ConvaTec Inc.
  • 4. Fosmo Med, Inc. |
  • 5. Fresenius Kabi AG
  • 6. ICU Medical Inc.
  • 7. Kawasumi Laboratories. Inc.
  • 8. Kraton Corporation.
  • 9. McKesson Medical-Surgical Inc.
  • 10. Pall Corporation
  • 11. Pfizer Inc.
  • 12. Polifarma Ilac San. ve Tic. A.S.
  • 13. RENOLIT SE
  • 14. Sippex IV bag
  • 15. Wipak Walothen Gmbh
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦